Fecal microbiota transplants (FMTs) recently entered the cancer therapeutics field as a method to resensitize treatment-resistant melanoma patients to immune checkpoint inhibitors (ICIs). In this issue of Cell Host & Microbe, Kim and colleagues extend its utility to other solid tumors, including esophageal and hepatocellular carcinomas.¹

中文翻译：

---

从粪便到承诺：粪便微生物群移植支持实体瘤免疫治疗的再敏化

粪便微生物移植（FMT）最近进入了癌症治疗领域，作为一种使难治性黑色素瘤患者对免疫检查点抑制剂（ICIs）重新敏感的方法。在本期《细胞宿主与微生物》中，Kim 及其同事将其实用性扩展到其他实体瘤，包括食管癌和肝细胞癌。 ¹